In principal cells of rat cortical collecting ducts (CCD) the K+ conductance of the basolateral membrane is functionally coupled to the Na+-K+-ATPase. Inhibition of the Na+-K+-ATPase by ouabain resulted in a decrease of this conductance. This inhibition was absent in the presence of amiloride. In the present study we attempted to measure the activities of intracellular Na+ ([Na+]i) and intracellular Ca2+ ([Ca2+]i) fluorimetrically, and discuss their role for the functional coupling of the activity of the Na+-K+ pump and the recently identified K+ channels in the basolateral membrane. [Na+]i and [Ca2+]i were measured in isolated CCD segments using the Na+-sensitive dye sodium-binding benzofuran isophthalate (SBFi) and the Ca2+-sensitive dye fura-2 as fluorescence indicators. Basal [Na+]i and [Ca2+]i were 22 ± 4 mM(n = 23) and 84 ± 13 nM(n = 28), respectively. With amiloride (10µM) [Na+]i and [Ca2+]i decreased by 5 ± 1 mM(n= 18) and by 19+9 nM(n = 21), respectively. With ouabain (0.5 mM), [Na+]i and [Ca2+]i increased by 30+7 mM (n = 7) and by 25+10 nM (n = 13), respectively. In the presence of amiloride, ouabain increased [Na+]i by only 8 ± 3 mM(n = 7), while [Ca2+]i did not change significantly (Δ = -2 ± 3 nM, n = 13). The observed parallel changes in [Ca2+]i and [Na+]j are compatible with the function of the Na+/Ca2+ exchanger present in the basolateral membrane of the CCD. The K+ channels in the basolateral membrane of rat CCD are inhibited by increases in [Ca2+]i. These data suggest the changes in [Na+]i and consecutive changes in [Ca2+]i as possible functional link between the K+ conductance of the basolateral membrane and the Na+-K+-ATPase of rat CCD.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.